Cargando…
Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab
INTRODUCTION: Chemoradiotherapy with taxanes is well-recognized as a first-line therapy for cutaneous angiosarcoma (CAS), but second-line therapy for CAS is still controversial. CASE PRESENTATION: In this report, we described a 75-year-old Japanese case of recurrent, tumor mutation burden-high CAS o...
Autores principales: | Amagai, Ryo, Fujimura, Taku, Kambayashi, Yumi, Ohuchi, Kentaro, Yamazaki, Emi, Hashimoto, Akira, Asano, Yoshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684255/ https://www.ncbi.nlm.nih.gov/pubmed/38033417 http://dx.doi.org/10.1159/000534657 |
Ejemplares similares
-
Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases
por: Ohuchi, Kentaro, et al.
Publicado: (2022) -
CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas
por: Yamamoto, Jun, et al.
Publicado: (2023) -
Cutaneous angiosarcoma treated with taxane‐based chemoradiotherapy: A multicenter study of 90 Japanese cases
por: Fujimura, Taku, et al.
Publicado: (2022) -
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
por: Amagai, Mayuko, et al.
Publicado: (2022) -
Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)